Meet The Scientist Episode 1: Gabriela Gomez

In Amsterdam, we sat down with Gabriela Gomez, senior director of global access at IAVI, to discuss her work using modeling to understand the potential impact of a new tuberculosis (TB) vaccine. As the COVID-19 pandemic has waned, TB once again has become the leading infectious cause of death in much of the world. In 2021, an estimated 1.6 million people died as a result of TB disease, making a new TB vaccine all the more vital. Gabriela Gomez also uses modeling to better understand how a new TB vaccine can be developed and distributed in an equitable and accessible way.

This podcast will explore the importance of epidemiology—a branch of medical science that investigates all the factors that determine the presence or absence of diseases—in TB vaccine R&D and global health access in general. Listen to the first episode of our new series Meet The Scientist to learn more about how IAVI is using epidemiology to develop affordable, globally accessible vaccines and antibodies.